We've found
2,298
archived clinical trials in
Insomnia Sleep Studies
We've found
2,298
archived clinical trials in
Insomnia Sleep Studies
Sleep, Pain and Inflammatory Processes in Older Adults With Osteoarthritis
Updated: 1/18/2016
Slow Wave Sleep and Inflammatory Processes in Pain
Status: Enrolling
Updated: 1/18/2016
Sleep, Pain and Inflammatory Processes in Older Adults With Osteoarthritis
Updated: 1/18/2016
Slow Wave Sleep and Inflammatory Processes in Pain
Status: Enrolling
Updated: 1/18/2016
Click here to add this to my saved trials
Telemedicine Interventions for Obstructive Sleep Apnea (OSA)
Updated: 1/20/2016
An RCT of Telemedicine Interventions for OSA
Status: Enrolling
Updated: 1/20/2016
Telemedicine Interventions for Obstructive Sleep Apnea (OSA)
Updated: 1/20/2016
An RCT of Telemedicine Interventions for OSA
Status: Enrolling
Updated: 1/20/2016
Click here to add this to my saved trials
A Double-Blind, Placebo-Controlled, Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia
Updated: 1/20/2016
A Double-Blind, Placebo-Controlled, Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia
Status: Enrolling
Updated: 1/20/2016
A Double-Blind, Placebo-Controlled, Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia
Updated: 1/20/2016
A Double-Blind, Placebo-Controlled, Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia
Status: Enrolling
Updated: 1/20/2016
Click here to add this to my saved trials
Sleep Disordered Breathing and Chronic Pain
Updated: 1/22/2016
BiPAP Adaptive Servo-Ventilation (AutoSV) Therapy in Patients With Chronic Pain and Sleep Disordered Breathing (SDB)
Status: Enrolling
Updated: 1/22/2016
Sleep Disordered Breathing and Chronic Pain
Updated: 1/22/2016
BiPAP Adaptive Servo-Ventilation (AutoSV) Therapy in Patients With Chronic Pain and Sleep Disordered Breathing (SDB)
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Sleep Disordered Breathing and Chronic Pain
Updated: 1/22/2016
BiPAP Adaptive Servo-Ventilation (AutoSV) Therapy in Patients With Chronic Pain and Sleep Disordered Breathing (SDB)
Status: Enrolling
Updated: 1/22/2016
Sleep Disordered Breathing and Chronic Pain
Updated: 1/22/2016
BiPAP Adaptive Servo-Ventilation (AutoSV) Therapy in Patients With Chronic Pain and Sleep Disordered Breathing (SDB)
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Sleep Disordered Breathing and Chronic Pain
Updated: 1/22/2016
BiPAP Adaptive Servo-Ventilation (AutoSV) Therapy in Patients With Chronic Pain and Sleep Disordered Breathing (SDB)
Status: Enrolling
Updated: 1/22/2016
Sleep Disordered Breathing and Chronic Pain
Updated: 1/22/2016
BiPAP Adaptive Servo-Ventilation (AutoSV) Therapy in Patients With Chronic Pain and Sleep Disordered Breathing (SDB)
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Sleep Disordered Breathing and Chronic Pain
Updated: 1/22/2016
BiPAP Adaptive Servo-Ventilation (AutoSV) Therapy in Patients With Chronic Pain and Sleep Disordered Breathing (SDB)
Status: Enrolling
Updated: 1/22/2016
Sleep Disordered Breathing and Chronic Pain
Updated: 1/22/2016
BiPAP Adaptive Servo-Ventilation (AutoSV) Therapy in Patients With Chronic Pain and Sleep Disordered Breathing (SDB)
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Adjunctive Brief Behavioral Treatment of Insomnia (BBTI) for Sleep Intervention (SI)
Updated: 1/25/2016
An Adjunctive Behavioral Sleep Intervention to Prevent Veteran Suicides
Status: Enrolling
Updated: 1/25/2016
Adjunctive Brief Behavioral Treatment of Insomnia (BBTI) for Sleep Intervention (SI)
Updated: 1/25/2016
An Adjunctive Behavioral Sleep Intervention to Prevent Veteran Suicides
Status: Enrolling
Updated: 1/25/2016
Click here to add this to my saved trials
Cognitive Behavioral Insomnia Therapy for Individuals With Fibromyalgia
Updated: 1/28/2016
Behavioral Insomnia Therapy With Fibromyalgia
Status: Enrolling
Updated: 1/28/2016
Cognitive Behavioral Insomnia Therapy for Individuals With Fibromyalgia
Updated: 1/28/2016
Behavioral Insomnia Therapy With Fibromyalgia
Status: Enrolling
Updated: 1/28/2016
Click here to add this to my saved trials
Click here to add this to my saved trials
Development of an Insomnia Treatment for Depressed Adolescents
Updated: 1/28/2016
Development of an Insomnia Treatment for Depressed Adolescents
Status: Enrolling
Updated: 1/28/2016
Development of an Insomnia Treatment for Depressed Adolescents
Updated: 1/28/2016
Development of an Insomnia Treatment for Depressed Adolescents
Status: Enrolling
Updated: 1/28/2016
Click here to add this to my saved trials
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Click here to add this to my saved trials
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Click here to add this to my saved trials
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Click here to add this to my saved trials
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Click here to add this to my saved trials
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Click here to add this to my saved trials
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Click here to add this to my saved trials
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Click here to add this to my saved trials
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Click here to add this to my saved trials
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Updated: 2/1/2016
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Click here to add this to my saved trials
Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia
Updated: 2/2/2016
Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia: a 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study
Status: Enrolling
Updated: 2/2/2016
Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia
Updated: 2/2/2016
Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia: a 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study
Status: Enrolling
Updated: 2/2/2016
Click here to add this to my saved trials
Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia
Updated: 2/2/2016
Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia: a 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study
Status: Enrolling
Updated: 2/2/2016
Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia
Updated: 2/2/2016
Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia: a 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study
Status: Enrolling
Updated: 2/2/2016
Click here to add this to my saved trials
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties
Updated: 2/5/2016
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties: a 6-week, Randomized, Double-blind, Placebo-controlled, Polysomnography Study.
Status: Enrolling
Updated: 2/5/2016
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties
Updated: 2/5/2016
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties: a 6-week, Randomized, Double-blind, Placebo-controlled, Polysomnography Study.
Status: Enrolling
Updated: 2/5/2016
Click here to add this to my saved trials
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties
Updated: 2/5/2016
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties: a 6-week, Randomized, Double-blind, Placebo-controlled, Polysomnography Study.
Status: Enrolling
Updated: 2/5/2016
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties
Updated: 2/5/2016
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties: a 6-week, Randomized, Double-blind, Placebo-controlled, Polysomnography Study.
Status: Enrolling
Updated: 2/5/2016
Click here to add this to my saved trials
Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children
Updated: 2/8/2016
A Phase II, Randomized, Placebo-controlled, Double Blind, Cross-over, Study of the Effects of Gabapentin on Chronic Irritability in Neurologically Impaired Children
Status: Enrolling
Updated: 2/8/2016
Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children
Updated: 2/8/2016
A Phase II, Randomized, Placebo-controlled, Double Blind, Cross-over, Study of the Effects of Gabapentin on Chronic Irritability in Neurologically Impaired Children
Status: Enrolling
Updated: 2/8/2016
Click here to add this to my saved trials
Sleep Length and Circadian Regulation in Humans
Updated: 2/9/2016
Sleep Length and Circadian Regulation in Humans
Status: Enrolling
Updated: 2/9/2016
Sleep Length and Circadian Regulation in Humans
Updated: 2/9/2016
Sleep Length and Circadian Regulation in Humans
Status: Enrolling
Updated: 2/9/2016
Click here to add this to my saved trials
CBT-I Intervention for Insomnia in Newly Diagnosed Cancer Patients
Updated: 2/9/2016
Testing an Accessible Cognitive Behavioral Therapy for Insomnia (CBT-I) Intervention in Newly Diagnosed Cancer Patients
Status: Enrolling
Updated: 2/9/2016
CBT-I Intervention for Insomnia in Newly Diagnosed Cancer Patients
Updated: 2/9/2016
Testing an Accessible Cognitive Behavioral Therapy for Insomnia (CBT-I) Intervention in Newly Diagnosed Cancer Patients
Status: Enrolling
Updated: 2/9/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Updated: 2/11/2016
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia
Updated: 2/12/2016
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly Subjects With Primary Chronic Insomnia
Status: Enrolling
Updated: 2/12/2016
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia
Updated: 2/12/2016
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly Subjects With Primary Chronic Insomnia
Status: Enrolling
Updated: 2/12/2016
Click here to add this to my saved trials
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia
Updated: 2/12/2016
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly Subjects With Primary Chronic Insomnia
Status: Enrolling
Updated: 2/12/2016
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia
Updated: 2/12/2016
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly Subjects With Primary Chronic Insomnia
Status: Enrolling
Updated: 2/12/2016
Click here to add this to my saved trials